These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4095828)
1. The oxalate-tolerance-value: a whole urine method to discriminate between calcium oxalate-stoneformers and others. Briellmann T; Hering F; Seiler H; Rutishauser G Urol Res; 1985; 13(6):291-5. PubMed ID: 4095828 [TBL] [Abstract][Full Text] [Related]
2. Investigations on macromolecular precipitation inhibitors of calcium oxalate. Schnierle P; Sialm F; Seiler HG; Hering F; Rutishauser G Urol Res; 1992; 20(1):7-11. PubMed ID: 1736490 [TBL] [Abstract][Full Text] [Related]
3. Measurement of calcium phosphate crystalluria: influence of pH and osmolality and invariable presence of oxalate. Hallson PC; Rose GA Br J Urol; 1989 Nov; 64(5):458-62. PubMed ID: 2611613 [TBL] [Abstract][Full Text] [Related]
4. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581 [TBL] [Abstract][Full Text] [Related]
5. The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine. Gohel MD; Shum DK; Li MK Urol Res; 1992; 20(1):13-7. PubMed ID: 1736481 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay. Hallson PC; Rose GA Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612 [TBL] [Abstract][Full Text] [Related]
7. Urinary macromolecules are promoters of calcium oxalate nucleation in human urine: turbidimetric studies. Rodgers AL; Ball D; Harper W Clin Chim Acta; 1993 Nov; 220(2):125-34. PubMed ID: 8111957 [TBL] [Abstract][Full Text] [Related]
8. Variations in urine composition during the day in patients with calcium oxalate stone disease. Ahlstrand C; Larsson L; Tiselius HG J Urol; 1984 Jan; 131(1):77-81. PubMed ID: 6537822 [TBL] [Abstract][Full Text] [Related]
9. The effect of pH on the urinary inhibition of calcium oxalate crystal growth. Tiselius HG Br J Urol; 1981 Oct; 53(5):470-4. PubMed ID: 6793122 [TBL] [Abstract][Full Text] [Related]
14. Urinary calcium oxalate saturation in 'stone formers' and normal subjects: an application of the EQUIL2 program. Robert M; Boularan AM; Colette C; Averous M; Monnier L Br J Urol; 1994 Apr; 73(4):358-61. PubMed ID: 8199821 [TBL] [Abstract][Full Text] [Related]
15. Evening urinary oxalate excretion in stone formers. Banks JG; Sullivan M; Hargreave TB Br J Urol; 1979 Oct; 51(5):349-51. PubMed ID: 533589 [TBL] [Abstract][Full Text] [Related]
16. Gender differences in seasonal variation of urine stone risk factors. Parks JH; Barsky R; Coe FL J Urol; 2003 Aug; 170(2 Pt 1):384-8. PubMed ID: 12853781 [TBL] [Abstract][Full Text] [Related]
17. Chemical factors governing the state of saturation towards brushite and whewellite in urine of calcium stone formers. Ackermann D; Baumann JM Urol Res; 1987; 15(2):63-5. PubMed ID: 3590430 [TBL] [Abstract][Full Text] [Related]
18. Diurnal variation in calcium-oxalate supersaturation level in normal and stone-forming urine. Ogawa Y; Takahashi S; Kitagawa R; Umeyama T; Aoyagi K Nihon Jinzo Gakkai Shi; 1983 Sep; 25(9):1127-30. PubMed ID: 6686620 [No Abstract] [Full Text] [Related]
19. The effect of serum on the crystallization of calcium oxalate in whole human urine: inhibition disguised as apparent promotion. Edyvane KA; Ryall RL; Mazzachi RD; Marshall VR Urol Res; 1987; 15(2):87-92. PubMed ID: 3590435 [TBL] [Abstract][Full Text] [Related]